Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes
Muttiah Barathan, Kaliappan Gopal, Rosmawati Mohamed, et al.
APOPTOSIS (2015) Vol. 20, Iss. 4, pp. 466-480
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Lymphopenia in COVID‐19: Therapeutic opportunities
Nazanin Fathi, Nima Rezaei
Cell Biology International (2020) Vol. 44, Iss. 9, pp. 1792-1797
Open Access | Times Cited: 322
T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses
Alireza Saeidi, Keivan Zandi, Yi Ying Cheok, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 284
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
Mady Hornig, José G. Montoya, Nancy G. Klimas, et al.
Science Advances (2015) Vol. 1, Iss. 1
Open Access | Times Cited: 233
CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?
Alexandra Miggelbrink, Joshua Jackson, Selena Lorrey, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 21, pp. 5742-5752
Open Access | Times Cited: 172
Peripheral and lung resident memory T cell responses against SARS-CoV-2
Judith Grau-Expósito, Nerea Sánchez-Gaona, Núria Massana, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 142
Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma
Tai Hato, Andrew X. Zhu, Dan G. Duda
Immunotherapy (2016) Vol. 8, Iss. 3, pp. 299-313
Open Access | Times Cited: 134
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
James J. Harding, Imane El Dika, Ghassan K. Abou‐Alfa
Cancer (2015) Vol. 122, Iss. 3, pp. 367-377
Open Access | Times Cited: 119
Immune Cells and Inflammation in Diabetic Nephropathy
Zihan Zheng, Feng Zheng
Journal of Diabetes Research (2015) Vol. 2016, pp. 1-10
Open Access | Times Cited: 116
Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8+ T cells
Arnaud Delpoux, Rodrigo Hess Michelini, Shilpi Verma, et al.
The Journal of Experimental Medicine (2017) Vol. 215, Iss. 2, pp. 575-594
Open Access | Times Cited: 75
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
Shaimaa Shouman, Nada Elkholy, Alaa E. Hussien, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
A Lipidomics Approach in the Characterization of Zika-Infected Mosquito Cells: Potential Targets for Breaking the Transmission Cycle
Carlos Fernando Odir Rodrigues Melo, Diogo Noin de Oliveira, Estela de Oliveira Lima, et al.
PLoS ONE (2016) Vol. 11, Iss. 10, pp. e0164377-e0164377
Open Access | Times Cited: 54
Specific CD8+T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis
E. Moreno-Cubero, J.R. Larrubia
World Journal of Gastroenterology (2016) Vol. 22, Iss. 28, pp. 6469-6469
Open Access | Times Cited: 53
Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells
Martine Kallemeijn, Anne Mieke H. Boots, Michèle Y. van der Klift, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 41
Check point inhibitors as therapies for infectious diseases
Maureen A. Cox, Robert Nechanitzky, Tak W. Mak
Current Opinion in Immunology (2017) Vol. 48, pp. 61-67
Closed Access | Times Cited: 38
Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment
Genhao Zhang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma
Tom Tan-To Cheung, Philip Chong‐hei Kwok, Stephen L. Chan, et al.
Liver Cancer (2018) Vol. 7, Iss. 1, pp. 40-54
Open Access | Times Cited: 32
Viral Persistence and Chronicity in Hepatitis C Virus Infection: Role of T-Cell Apoptosis, Senescence and Exhaustion
Muttiah Barathan, Rosmawati Mohamed, Yean K. Yong, et al.
Cells (2018) Vol. 7, Iss. 10, pp. 165-165
Open Access | Times Cited: 31
Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
Kashif Asghar, Asim V. Farooq, Bilal Zulfiqar, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 13, pp. 2286-2286
Open Access | Times Cited: 29
CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptides
Muttiah Barathan, Rosmawati Mohamed, Jamuna Vadivelu, et al.
Cellular Immunology (2016) Vol. 313, pp. 1-9
Closed Access | Times Cited: 27
A bioinformatics investigation into the pharmacological mechanisms of the effect of the Yinchenhao decoction on hepatitis C based on network pharmacology
Jingyuan Zhang, Xinkui Liu, Jiarui Wu, et al.
BMC Complementary Medicine and Therapies (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 26
Immune checkpoint blockade in advanced hepatocellular carcinoma: an update and critical review of ongoing clinical trials
James J. Harding
Future Oncology (2018) Vol. 14, Iss. 22, pp. 2293-2302
Open Access | Times Cited: 27
Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers
Guoying Zhou, Patrick P.C. Boor, Marco J. Bruno, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 1, pp. 10-23
Open Access | Times Cited: 20
Multiomic profiling of chronically activated CD4+ T cells identifies drivers of exhaustion and metabolic reprogramming
Matthew Lawton, Melissa M. Inge, Benjamin C. Blum, et al.
PLoS Biology (2024) Vol. 22, Iss. 12, pp. e3002943-e3002943
Open Access | Times Cited: 2
The Promise of Immunotherapy in the Treatment of Hepatocellular Carcinoma
Anthony B. El-Khoueiry
American Society of Clinical Oncology Educational Book (2017), Iss. 37, pp. 311-317
Open Access | Times Cited: 21
Increased frequency of late‐senescent T cells lacking CD127 in chronic hepatitis C disease
Muttiah Barathan, Rosmawati Mohamed, Alireza Saeidi, et al.
European Journal of Clinical Investigation (2015) Vol. 45, Iss. 5, pp. 466-474
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top